Dalia Barsyte-Lovejoy

Dalia Barsyte-Lovejoy

Auto-generated profile, based on publicly available information

Dalia Barsyte-Lovejoy

Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Journal of Chemical Neuroanatomy
Verified
Journal Article
Closed access
DLDavid A. Lovejoy
David A. Lovejoy
LLLouise de Lannoy
Louise de Lannoy

7 April 2014 in Journal of Molecular Endocrinology
Verified
Journal Article
Closed access
DLDavid A Lovejoy
David A Lovejoy
BCBelinda S W Chang
Belinda S W Chang
NLNathan R Lovejoy
Nathan R Lovejoy
JCJon del Castillo
Jon del Castillo
Corticotrophin-releasing hormone (CRH) is the pivotal neuroendocrine peptide hormone associated with the regulation of the stress response in vertebrates. However, CRH-like peptides are also found in a number of invertebrate species. The origin of this peptide can be traced to a common ancestor of lineages leading to chordates and to arthropods, postulated to occur some 500 million years ago. Evidence indicates the presence of a single CRH-like receptor and a soluble binding protein system that acted to transduce and regulate the actions of the early CRH peptide. In vertebrates, genome duplications led to the divergence of CRH receptors into CRH1 and CRH2 forms in tandem with the development of four paralogous ligand lineages that included CRH; urotensin I/urocortin (Ucn), Ucn2 and Ucn3. In addition, taxon-specific genome duplications led to further local divergences in CRH ligands and receptors. Functionally, the CRH ligand–receptor system evolved initially as a molecular system to integrate early diuresis and nutrient acquisition. As multicellular organisms evolved into more complex forms, this ligand–receptor system became integrated with the organismal stress response to coordinate homoeostatic challenges with internal energy usage. In vertebrates, CRH and the CRH1 receptor became associated with the hypothalamo-pituitary–adrenal/interrenal axis and the initial stress response, whereas the CRH2 receptor was selected to play a greater role in diuresis, nutrient acquisition and the latter aspects of the stress response.

1 October 2009 in General and Comparative Endocrinology
Verified
Journal Article
Closed access
DLDavid A. Lovejoy
David A. Lovejoy

24 April 2015 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
RWRebecca Woelfle
Rebecca Woelfle
ADAndrea L. D'Aquila
Andrea L. D'Aquila
TPTéa Pavlović
Téa Pavlović
MHMia Husić
Mia Husić
DLDavid A. Lovejoy
David A. Lovejoy
Teneurins are multifunctional transmembrane proteins that are found in all multicellular animals and exist as four paralogous forms in vertebrates. They are highly expressed in the central nervous system, where they exert their effects, in part, by high-affinity binding to latrophilin (LPHN), a G-protein coupled receptor (GPCR) related to the adhesion and secretin GPCR families. The teneurin C-terminal associated peptides (TCAPs) are encoded by the terminal exon of all four teneurins, where TCAPs 1 and 3 are independently transcribed as soluble peptides, and TCAPs 2 and 4 remain tethered to their teneurin proprotein. Synthetic TCAP-1 interacts with LPHN, with an association with β-dystroglycan to induce a tissue-dependent signal cascade to modulate cytoskeletal dynamics. TCAP-1 reduces stress-induced behaviours associated with anxiety, addiction and depression in a variety of models, in part, by regulating synaptic plasticity. Therefore, the TCAP-1-teneurin-LPHN interaction represents a novel receptor-ligand model and may represent a key mechanism underlying the association of behaviour and neurological conditions.

1 January 2010 in General and Comparative Endocrinology
Verified
Journal Article
Closed access
DLDavid A. Lovejoy
David A. Lovejoy
DBDalia Barsyte-Lovejoy
Dalia Barsyte-Lovejoy

1 January 2016 in Translational Neuroscience
Verified
Journal Article
Open access
PDF file
RWRebecca Woelfle
Rebecca Woelfle
ADAndrea L. D’aquila
Andrea L. D’aquila
DLDavid A. Lovejoy
David A. Lovejoy
Mood disorders, including anxiety and depression, are thought to be characterized by disrupted neuronal synapses and altered brain plasticity. The etiology is complex, involving numerous regions of the brain, comprising a multitude of neurotransmitter and neuromodulator systems. Recently, new studies on the teneurins, an evolutionary ancient family of type II transmembrane proteins have been shown to interact with latrophilins (LPHN), a similarly phylogenetically old family of adhesion G protein-coupled receptors (GPCR) forming a transsynaptic adhesion and ligand-receptor pair. Each of the four teneurin proteins contains bioactive sequences termed the teneurin C-terminal associated peptides (TCAP-1–4), which possess a number of neuromodulatory effects. The primary structures of the TCAP are most closely similar to the corticotropin-releasing factor (CRF) family of peptides. CRF has been implicated in a number of diverse mood disorders. Via an association with dystroglycans, synthetic TCAP-1 administration to both embryonic and primary hippocampal cultures induces long-term changes in neuronal structure, specifically increased neurite outgrowth, dendritic branching, and axon growth. Rodent models treated with TCAP-1 show reduced anxiety responses in the elevated plus-maze, openfield test, and acoustic startle test and inhibited CRF-mediated cocaine-seeking behaviour. Thus the teneurin/TCAP-latrophilin interaction may play a major role in the origin, development and treatment of mood disorders.